Editorial policy

Research process

Editorial work starts with the mechanism, then checks human evidence, clinical-trial records, regulatory status, safety signals, and product context. Pages separate studied endpoints from informal claims.

Source hierarchy

Primary studies, clinical trials, systematic reviews, regulatory bodies, and official sport-governance sources carry the most weight. Vendor claims and user anecdotes are treated as lower-quality evidence.

Conflict of interest policy

Affiliate relationships may exist with vendors linked from the site. Commission potential should not change page conclusions, safety notes, or source selection.

Review and refresh cycle

Every article, peptide database entry, and product page is reviewed about every six months. One pass checks each page against current knowledge and fixes errors, stale facts, and dead links. A second pass looks for new trial results, regulatory decisions, delivery technology, and community trends, then updates existing pages or adds new ones. Time-sensitive facts are written with the month and year they were checked, so the next cycle can recheck them.

Sources are included broadly and labeled by type in the text: clinical trials, animal and lab studies, preprints, regulatory documents, news, vendor materials, and community reports from forums and user surveys. Labels let readers weigh each claim, and the source hierarchy above still decides how much weight it carries. Dosing information is reported as what studies used or what users describe, never as a recommendation. Corrections from readers and from each review cycle are applied in the next update.

Corrections

Correction requests should include the page URL, the claim in question, and the source that supports the correction. A verified contact channel is still needed for the final request process.

AI assistance disclosure

AI tools may assist with drafting, formatting, and consistency checks. Human review is required before publication, especially for medical, legal, regulatory, and citation-sensitive claims.